drumming,
Long time, no see! Thanks for your kind words.
Over the years, investment in VPLM was a big challenge for many investors. They do not appear to have background or knowledge in:
USPTO Patent Act, patents and claims, fait market value of patents, royalty and licensing, infringement and remedies, IP business aspects, court proceedings especially NDCal's clueless woman's arrogance and ignorance, twisting Declaratory Judgement into defendants' favor, etc. On the other hand, those with the required background and knowledge do not post here. We are dealing with only 2 of the 8 patents so far: RBR and MG. The current issue involves only the MG patent. You know the history.
The upcoming session in Jan 2023 deals with Experts testimony from both sides. Judge Albright may listen to both sides to help with his conclusions - as the Law states. Not like selling in a "flea market", ignorant of fair market value of the MG patent in question. They the RBR patent and six more patents. How many investors have read the two patents (RBR and MG) or all of the eight patents?
Many talk about a "settlement", without any idea about the level of negotiations involved and how long it takes to arrive at a fair market value. It may be specific to each defendant. If Judge Albright's elegant analysis of "AMZN transfer denial" order is upheld by CFAC, we can expect the Judge to be careful with the infringement award to compensate VPLM for "Reasonable Royalties" lost provided by Patent Act, US Code 284.
News 
Market Data 
Discover 
